4,943 Shares in Colgate-Palmolive (CL) Purchased by Charter Research & Investment Group Inc.
Charter Research & Investment Group Inc. bought a new stake in Colgate-Palmolive (NYSE:CL) during the fourth quarter, HoldingsChannel.com reports. The fund bought 4,943 shares of the company’s stock, valued at approximately $373,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Colgate-Palmolive by 42.4% during the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after purchasing an additional 2,903,800 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of Colgate-Palmolive by 25.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after purchasing an additional 1,385,946 shares in the last quarter. First Eagle Investment Management LLC grew its holdings in shares of Colgate-Palmolive by 35.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after purchasing an additional 1,750,417 shares in the last quarter. Finally, APG Asset Management N.V. grew its holdings in shares of Colgate-Palmolive by 33.2% during the 4th quarter. APG Asset Management N.V. now owns 5,421,184 shares of the company’s stock worth $340,630,000 after purchasing an additional 1,350,400 shares in the last quarter. 72.85% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive (CL) opened at $69.76 on Monday. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 52-week low of $66.47 and a 52-week high of $77.91. The company has a market capitalization of $61,256.62, a P/E ratio of 24.31, a P/E/G ratio of 2.58 and a beta of 0.75.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. The ex-dividend date is Monday, January 22nd. This represents a $1.60 annualized dividend and a yield of 2.29%. Colgate-Palmolive’s payout ratio is 70.18%.
In other Colgate-Palmolive news, COO Noel R. Wallace sold 126,304 shares of Colgate-Palmolive stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the completion of the transaction, the chief operating officer now owns 305,631 shares in the company, valued at approximately $22,549,455.18. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 327,451 shares of company stock valued at $23,534,707. Corporate insiders own 1.02% of the company’s stock.
CL has been the subject of several analyst reports. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Jefferies Group cut their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research report on Monday, October 30th. Finally, Morgan Stanley cut their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research report on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company’s stock. Colgate-Palmolive has an average rating of “Hold” and an average target price of $77.71.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.